FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895802017> ?p ?o ?g. }

• W2895802017 endingPage "1062" @default.
• W2895802017 startingPage "1054" @default.
• W2895802017 abstract "BACKGROUND: Organ ischemia-reperfusion injury often induces local and systemic inflammatory responses, which in turn worsen organ injury. These inflammatory responses can be regulated by the central nervous system, particularly by the vagal nerve and nicotinic acetylcholine receptors, which are the key components of cholinergic anti-inflammatory pathway. Activation of the cholinergic anti-inflammatory pathway can suppress excessive inflammatory responses and be a potential strategy for prevention of ischemia-reperfusion injury of organs including the kidney. METHODS: Vagal nerve activity, plasma acetylcholine, catecholamine and inflammatory mediators, renal tissue injury, and cell death were measured in mice with bilateral renal ischemia/reperfusion with or without treatment with dexmedetomidine (Dex), an α2-adrenergic receptor agonist. RESULTS: Dex significantly increased the discharge frequency of the cervical vagal nerve by up to 142 Hz (mean) (P < .001), and preserved kidney gross morphology and structure and attenuated cell apoptosis after ischemia-reperfusion. Furthermore, Dex also significantly increased acetylcholine release to 135.8 pmol/L (median) when compared to that (84.7 pmol/L) in the sham group (P < .001) and reduced the levels of several inflammatory mediators induced by renal ischemia/reperfusion. All the effects were abolished by vagotomy, splenectomy, or combinative administration of atipamezole, an α2-adrenergic receptor antagonist. CONCLUSIONS: Our findings suggest that Dex provides renoprotection, at least in part, through anti-inflammatory effects of the parasympathetic nervous system activation in addition to its direct actions on α2-adrenergic receptors." @default.
• W2895802017 created "2018-10-26" @default.
• W2895802017 creator A5003785884 @default.
• W2895802017 creator A5008357796 @default.
• W2895802017 creator A5016955733 @default.
• W2895802017 creator A5021064727 @default.
• W2895802017 creator A5037458498 @default.
• W2895802017 creator A5057842365 @default.
• W2895802017 creator A5060358648 @default.
• W2895802017 creator A5065312383 @default.
• W2895802017 creator A5068290128 @default.
• W2895802017 creator A5084911441 @default.
• W2895802017 creator A5090375343 @default.
• W2895802017 date "2020-04-01" @default.
• W2895802017 modified "2023-09-26" @default.
• W2895802017 title "Dexmedetomidine-Mediated Prevention of Renal Ischemia-Reperfusion Injury Depends in Part on Cholinergic Anti-Inflammatory Mechanisms" @default.
• W2895802017 cites W1535531032 @default.
• W2895802017 cites W1967372050 @default.
• W2895802017 cites W1987943363 @default.
• W2895802017 cites W1995525413 @default.
• W2895802017 cites W2018424479 @default.
• W2895802017 cites W2041322579 @default.
• W2895802017 cites W2047522408 @default.
• W2895802017 cites W2054366648 @default.
• W2895802017 cites W2056879548 @default.
• W2895802017 cites W2059485573 @default.
• W2895802017 cites W2064705090 @default.
• W2895802017 cites W2069368135 @default.
• W2895802017 cites W2086246203 @default.
• W2895802017 cites W2088750369 @default.
• W2895802017 cites W2095346929 @default.
• W2895802017 cites W2101015806 @default.
• W2895802017 cites W2104645833 @default.
• W2895802017 cites W2114561453 @default.
• W2895802017 cites W2114821371 @default.
• W2895802017 cites W2123024844 @default.
• W2895802017 cites W2151660617 @default.
• W2895802017 cites W2169567979 @default.
• W2895802017 cites W2169644453 @default.
• W2895802017 cites W2340542419 @default.
• W2895802017 cites W2371948111 @default.
• W2895802017 cites W2415452092 @default.
• W2895802017 cites W2430394288 @default.
• W2895802017 cites W2474554183 @default.
• W2895802017 cites W2482661522 @default.
• W2895802017 cites W2505795647 @default.
• W2895802017 doi "https://doi.org/10.1213/ane.0000000000003820" @default.
• W2895802017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30346356" @default.
• W2895802017 hasPublicationYear "2020" @default.
• W2895802017 type Work @default.
• W2895802017 sameAs 2895802017 @default.
• W2895802017 citedByCount "35" @default.
• W2895802017 countsByYear W28958020172019 @default.
• W2895802017 countsByYear W28958020172020 @default.
• W2895802017 countsByYear W28958020172021 @default.
• W2895802017 countsByYear W28958020172022 @default.
• W2895802017 countsByYear W28958020172023 @default.
• W2895802017 crossrefType "journal-article" @default.
• W2895802017 hasAuthorship W2895802017A5003785884 @default.
• W2895802017 hasAuthorship W2895802017A5008357796 @default.
• W2895802017 hasAuthorship W2895802017A5016955733 @default.
• W2895802017 hasAuthorship W2895802017A5021064727 @default.
• W2895802017 hasAuthorship W2895802017A5037458498 @default.
• W2895802017 hasAuthorship W2895802017A5057842365 @default.
• W2895802017 hasAuthorship W2895802017A5060358648 @default.
• W2895802017 hasAuthorship W2895802017A5065312383 @default.
• W2895802017 hasAuthorship W2895802017A5068290128 @default.
• W2895802017 hasAuthorship W2895802017A5084911441 @default.
• W2895802017 hasAuthorship W2895802017A5090375343 @default.
• W2895802017 hasBestOaLocation W28958020171 @default.
• W2895802017 hasConcept C126322002 @default.
• W2895802017 hasConcept C134018914 @default.
• W2895802017 hasConcept C170493617 @default.
• W2895802017 hasConcept C22885893 @default.
• W2895802017 hasConcept C2775910092 @default.
• W2895802017 hasConcept C2776312488 @default.
• W2895802017 hasConcept C2776814716 @default.
• W2895802017 hasConcept C2776914184 @default.
• W2895802017 hasConcept C2777953023 @default.
• W2895802017 hasConcept C2778720886 @default.
• W2895802017 hasConcept C2778938600 @default.
• W2895802017 hasConcept C2779520467 @default.
• W2895802017 hasConcept C2780091579 @default.
• W2895802017 hasConcept C2780114680 @default.
• W2895802017 hasConcept C2781302539 @default.
• W2895802017 hasConcept C42219234 @default.
• W2895802017 hasConcept C541997718 @default.
• W2895802017 hasConcept C71924100 @default.
• W2895802017 hasConcept C84393581 @default.
• W2895802017 hasConcept C98274493 @default.
• W2895802017 hasConceptScore W2895802017C126322002 @default.
• W2895802017 hasConceptScore W2895802017C134018914 @default.
• W2895802017 hasConceptScore W2895802017C170493617 @default.
• W2895802017 hasConceptScore W2895802017C22885893 @default.
• W2895802017 hasConceptScore W2895802017C2775910092 @default.
• W2895802017 hasConceptScore W2895802017C2776312488 @default.
• W2895802017 hasConceptScore W2895802017C2776814716 @default.
• W2895802017 hasConceptScore W2895802017C2776914184 @default.

• next